7*24 Hotline：
Guangzhou Yangpu Medical Technology Co., Ltd. (300030)
Guangzhou Yangpu Medical Technology Co., Ltd. (hereinafter referred to as "Yangpu medical") was established in 1996. Its core business is clinical diagnosis, concomitant diagnosis, medical informatization and immunotherapy technology. In 2009, the company was listed on the gem with the stock code of 300030.
Yangpu medical is a national high-tech enterprise with independent innovation as its business orientation, and is a demonstration unit of medical device quality management enterprises in China. More than 300 R & D technicians of the company have formed five professional teams and a common platform, namely the Key Laboratory of blood compatibility of medical materials in Guangdong Province, hemostatic and coagulation product line research center, immunology product line research center, molecular diagnosis product line team, medical information product line team and active and passive medical device research common platform. In recent years, it has obtained more than 100 patent technologies, and its representative products include: liquid biopsy blood collection, multi-channel thromboelastography diagnosis system, LH ovulation monitor, automatic intelligent dry immunofluorescence analyzer, IBMS intelligent blood collection pipeline, multi drug in vitro induced immune cell preparation technology, etc., as well as several molecular diagnosis products, accompanying diagnosis products and immunodiagnosis products The product is being registered.
The company has provided product, technology and service support for more than 10000 medical institutions, research institutions and laboratories in more than 100 countries and regions, serving nearly 5.5 billion patients.
With the mission of providing "intelligent solutions for precision treatment", Yangpu medical has made every effort to carry out the construction of medical laboratory diagnosis and medical informatization. In the medical industry, Yangpu medical adheres to the concept of "being refined but not broad", takes the troika (general manager of product line, chief scientist and chief technology officer) as the core, vigorously promotes independent decision-making and organization of product line, focuses on IVD field and digital medical field, and extends from medical industry to medical service field when conditions permit.
oil wellhead